Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

21 projects found matching your search criteria :

  1. Simultaneous stimulation of muscarinic M4 receptor and selected receptors involved in the regulation of glutamate releas...

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: dr hab. Joanna Wierońska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  2. Development of optimization methods for dose selection of analgesic drugs used as a combination drug therapy in neuropat...

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: dr hab. Kinga Sałat

    Uniwersytet Jagielloński - Collegium Medicum, Uniwersytet Jagielloński - Collegium Medicum, Wydział Farmaceutyczny

  3. Anticancer activity of the thiosemicarbazone derivatives

    Call: SONATA 7 , Panel: NZ7

    Principal investigator: dr Anna Mrozek-Wilczkiewicz

    Uniwersytet Śląski w Katowicach, Wydział Matematyki, Fizyki i Chemii

  4. In vitro assessment of selected protumorigenic effects favoring breast cancer development after exposure to silver nanop...

    Call: OPUS 4 , Panel: NZ7

    Principal investigator: dr hab. Maciej Stępnik

    Instytut Medycyny Pracy im. prof. dr. med. Jerzego Nofera

  5. The influence of some selected antiepileptic drugs in combination with arachinodyl-2-chlorethylamide, a selective cannab...

    Call: OPUS 3 , Panel: NZ7

    Principal investigator: dr Marta Andres-Mach

    Instytut Medycyny Wsi im. Witolda Chodźki

  6. Combination therapy with naphthoquinones and paclitaxel in the pharmacological induction of cell death in breast cancer ...

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr Anna Kawiak

    UNIWERSYTET GDAŃSKI

  7. Development of novel anti-cancer immunotherapy against mesothelioma comprising of oncolytic adenovirus vectors armed wit...

    Call: SONATA 18 , Panel: NZ7

    Principal investigator: dr Łukasz Kuryk

    Narodowy Instytut Zdrowia Publicznego PZH - Państwowy Instytut Badawczy

  8. Combination of FAAH inhibition with action via serotonin 5-HT6 receptor as pioneering approach to fight with Alzheimer D...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Kinga Czarnota-Łydka

    Uniwersytet Jagielloński, Collegium Medicum

  9. Bioresorbable, electrospun nonwoven as a multi-drug delivery system for a combination glioblastoma therapy

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Monika Musiał-Kulik

    Centrum Materiałów Polimerowych i Węglowych Polskiej Akademii Nauk

  10. Assessment of virulence, biofilm formation and drug-susceptibility of Candida albicans treated with plant essential oils...

    Call: PRELUDIUM 1 , Panel: NZ6

    Principal investigator: Aleksandra Budzyńska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  11. Novel combination therapies of pulmonary arterial hypertension targeting blockade of peripheral cannabinoid CB1 receptor...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Barbara Malinowska

    Uniwersytet Medyczny w Białymstoku

  12. In search for molecular targets to overcome doxorubicin resistance in triple-negative breast cancer with the use of inno...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Anna Pogorzelska

    Narodowy Instytut Leków

  13. Drug repurposing to target p53 protein family for improved therapy in the relapsed TP53 and EGFR mutated lung cancer

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr Joanna Zawacka-Pankau

    Warszawski Uniwersytet Medyczny

  14. A novel approach based on the optimized multidrug combination for glioblastoma treatment.

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr Małgorzata Kucińska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  15. Systems of polyphenols with prebiotic carriers as combinations with unknown potential of biological activity

    Call: PRELUDIUM BIS 2 , Panel: NZ7

    Principal investigator: prof. Judyta Cielecka-Piontek

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  16. Combination of Molecular Simulation and Deep Learning for De Novo Drug Design

    Call: PRELUDIUM 19 , Panel: ST6

    Principal investigator: Tomasz Danel

    Uniwersytet Jagielloński, Wydział Matematyki i Informatyki

  17. Study on metabolism of microorganisms treated with metal nanoparticles, antibiotics, metal ions and their combinations u...

    Call: PRELUDIUM 13 , Panel: ST4

    Principal investigator: Agnieszka Rogowska

    Uniwersytet Mikołaja Kopernika, Wydział Chemii

  18. Old drugs - new perspectives: modulation of antibiotics activity by caffeine and pentoxifylline

    Call: SONATA 11 , Panel: NZ7

    Principal investigator: dr Anna Woziwodzka

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  19. Evaluation of novel, synergistic drug combinations for the treatment of B cell malignancies

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: dr Małgorzata Firczuk

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

  20. Modeling the relationship between structural features of modified TiO2 NPs and their cytotoxicity in vitro via a combina...

    Call: PRELUDIUM 10 , Panel: NZ7

    Principal investigator: Alicja Mikołajczyk

    Uniwersytet Gdański, Wydział Chemii

  21. The role of DNA methylation in enhancing the sensitivity of colorectal cancer cells to topoisomerase inhibitors.

    Call: PRELUDIUM 9 , Panel: NZ3

    Principal investigator: Alicja Pawlak

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda PAN

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy